Clinical endpoint | Prognosticator | HR | 95% CI | P value |
---|---|---|---|---|
OS | CXCR4 Expression | 2.78 | 1.78-4.35 | <0.001 |
UICC Stage | 1.51 | 1.15-1.98 | 0.003 | |
N classification | 1.47 | 1.16-1.88 | 0.001 | |
Gender | 0.48 | 0.29-0.80 | 0.004 | |
 | Age | 1.65 | 1.07-2.56 | 0.024 |
PFS | CXCR4 Expression | 2.30 | 1.42-3.72 | <0.001 |
ETAR Expression | 2.12 | 1.03-4.36 | 0.04 | |
 | N classification | 1.66 | 1.31-2.08 | <0.001 |
 | Gender | 0.38 | 0.21-0.72 | 0.003 |
DMFS | CXCR4 expression | 2.52 | 1.42-4.46 | 0.001 |
ETAR expression | 3.46 | 1.22-9.84 | 0.02 | |
 | N classification | 1.96 | 1.48-2.59 | <0.001 |
LRRFS | UICC stage | 1.76 | 1.22-2.54 | 0.002 |